Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DerMend Moisturizing Bruise Formula is a topical cosmetic cream designed to improve the appearance of bruising and photoaging in mature skin, particularly on the forearms and hands. Developed and evaluated in clinical trials by The Center for Clinical and Cosmetic Research, the formulation contains a proprietary blend of active ingredients including phytonadione (vitamin K), arnica oil, retinol, glycolic acid, niacinamide, and ceramides. These components work synergistically to restore the skin's protective barrier, enhance skin thickness, and reduce the visibility of bruises and signs of sun damage such as mottled hyperpigmentation and laxity. It is specifically marketed for individuals with chronically aged skin that is prone to easy bruising due to aging, sun damage, or medication use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on DerMend Moisturizing Bruise Formula.